Wpływ doustnego podania glinu na poziom wskaźników hematologicznych i biochemicznych krwi oraz jego zawartość w wybranych strukturach ośrodkowego układu nerwowego psów

• Autorzy: Gajda M. , Soltysiak Z.

Warianty tytułu

EN

Effect of orally administered aluminum on the level of hematological and biochemical blood indicators and its content in selected structures of the central nervous system of dogs

• Języki publikacji: PL

Abstrakty

EN

The objective of the study was to demonstrate the effect of oral administration of aluminum on the level of hematological and biochemical blood indicators, clinical symptoms and its contents in selected CNS structures in dogs. The study was conducted in two stages. The dogs were assigned to two groups. The experimental group was composed of 7 hybrid dogs (aged 12-17 years, 5 males and 2 females) which received 10 mg/kg aluminum sulphate orally over a period of 6 weeks. The control group was composed of 7 hybrid dogs (aged 13-20 years, 3 males and 4 females) which did not receive the preparation. 1 ml blood samples for hematological tests were collected from the cephalic vein (vena cephalica) to EDTA test tubes. The number of erythrocytes (RBC), hemoglobin concentration (Hb), hematocrit (Ht), the number of leukocytes and platelets were determined. The hematological test was conducted with the automatic analyzer unit by ABX Diagnostic. 5 ml blood samples were collected for the biochemical tests into test tubes with silicone spheres. Serum was obtained from full blood for 5 min. at 1500 × g. Serum was used to assess the activity of alanine aminotransferase (ALAT/GPT), aspartate aminotransferase (AspAT/GOT), alkaline phosphatise (ALP/AP/FA), level of calcium (with the POINTE 180 biochemical analyzer unit), magnesium, organic phosphorus (with the EPOLL 11 analyzer unit), sodium, potassium, and chlorine (with the CIBA CORNING 644 analyzer unit). After 42 days of administration of aluminum, an insignificant decrease in all morphological blood parameters was recorded in the experimental group, with a statistically significant decrease found in the concentrations of calcium and potassium in blood serum between the first day of the study and the 42nd day. The level of calcium in the experimental group was reduced. No statistically significant differences were found in the concentrations of sodium, magnesium, phosphorus and chlorine in the experimental group. However, a statistically significant increase was recorded in the content of aluminum in the cerebral cortex, hippocampus and cerebellum cortex in the experimental group.

Słowa kluczowe

PL

psy; glin; toksycznosc; neurotoksycznosc; podawanie doustne; badania krwi; wskazniki biochemiczne; wskazniki hematologiczne; uklad nerwowy osrodkowy; mozg; zawartosc glinu

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2015
• Tom: 71
• Numer: 08
• Opis fizyczny: s.505-509,tab.,bibliogr.

Twórcy

autor

Gajda M.

• Przychodnia weterynaryjna S.C., ul.Wolności 121D, 42-674 Zbrosławice

autor

Soltysiak Z.

• Zakład Parazytologii, Katedra Chorób Wewnętrznych z Kliniką Koni, Psów i Kotów, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy we Wrocławiu, ul. Norwida 31, 50-375 Wrocław

Bibliografia

• 1. Abreo K., Brown S. T., Sella M., Trapp G.: Application of an erythrocyte aluminium assay in the diagnosis of aluminium-associated microcyticanemia in patients undergoing dialisis and response to deferoxamine therapy. J. Lab. Clin. Med. 1989, 113, 50-57.
• 2. Abubakar M. G., Taylor A., Ferns G. A. A.: Regional accumulation of aluminium in the rat brain is affected by dietary vitamin E. J. Trace Med. Biol. 2004, 18, 53-59.
• 3. Bilkei-Gorzó A.: Neurotoxic effect of enternal aluminium. Fd. Chem. Toxic. 1993, 31, 357-361.
• 4. Campbell A., Becaria A., Lahiri D. K., Sharman K., Bondy S. C.: Chronic exposure to aluminium in drinking water increases inflammatory parameters selectively in the brain. J. Neurosci. Res. 2004, 75, 565-572.
• 5. Colomina M. T., Roig J. L., Sanchez D. J., Domingo J. L.: Influence of age on aluminium-induced neurobehavioral effects and morphological changes in rat brain. Neurotox. 2002, 23, 775-781.
• 6. Crichton R. R., Florence A., Ward R. J.: Aluminium and iron in the brain-prospects for chelation. Coord. Chem. Rev. 2002, 228, 365-371.
• 7. Darbre P. D.: Aluminium, antiperspirants and breast cancer. J. Inorg. Biochem. 2005, 99, 1912-1919.
• 8. Döllken V.: Über die Wirkung des Aluminiums mit besonderer Berücksichtigung der durch das Aluminium verursachten Läsionen im Zentralnervensystem. Nauym-Schmiedelbergs Arch. Exp. Pathol. Pharmac. 1887, 40, 58-61.
• 9. Driscoll C. T., Baker J. P., Bisogni J. J., Schofield C. L.: Effect of aluminium speciation on fish in dilute acidified waters. Nature 1980, 284, 161-164.
• 10. Ebina Y., Okada S., Hamazaki S., Midorikawa O.: Liver, kidney, and central nervous system toxicity of aluminium given intraperitoneally to rats: a multiple-dose subchronic study using aluminium nitrilotriacetate. Toxicol. Appl. Pharmacol. 1984, 75, 211-218.
• 11. Flaten T. P.: Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res. Bull. 2001, 55, 187-196.
• 12. Gromysz-Kałkowska K., Szubartowska E.: Glin – znaczenie ekologiczne i toksyczność dla zwierząt. Med. Weter. 1999, 55, 229-233.
• 13. Howard J. M. H.: Clinical import of small increases in serum aluminium. Clin. Chem. 1984, 30, 1722-1723.
• 14. Johnson V. J., Sharma R. P.: Aluminium disrupts the pro-inflammatory cytocine/neurotrophin balance in primary brain rotation-mediated aggregate cultures: possible role in neurodegeneration. Neurotox. 2003, 24, 261-268.
• 15. Johnson W. W., Barnes C. M., Covey D. A., Walker M. P., Ross J. A.: The effects of a commercial aluminum airpolishing powder on dental restorative materials. J. Prosthodont. 2004, 13, 166-172.
• 16. Kawahara M., Kato M., Kuroda Y.: Effects of aluminium on the neurotoxicity of primary cultured neurons and on the aggregation of β-amyloid protein. Brain Res. Bull. 2001, 55, 211-217.
• 17. Klatzo I., Wisniewski H. M., Streicher E.: Experimental production of neurofibrillary degeneration: I. light microscopic observations. J. Neuropathol. Exp. Neurol. 1965, 24, 187-199.
• 18. Martin R. B.: The chemistry of aluminium as related to biology and medicine. Clin. Chem. 1986, 32, 1797-1806.
• 19. McLaughlin A. I. G., Kazantzis G., King E.: Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminium dust. Br. J. Ind. Med. 1962, 19, 253-263.
• 20. Nowak P., Brus R.: Glin i niektóre schorzenia wieku dziecięcego. Przegl. Pediatr. 1997, 27, 201-204.
• 21. Oteiza P. I., Keen C. L., Han B., Golub M. S.: Aluminium accumulation and neurotoxicity in Swiss-Webster mice after long-term dietary exposure to aluminium and citrace. Metabolism 1993, 42, 1296-1300.
• 22. Perl D. P., Gajdusek D. C., Garruto R. M., Yangihara R. T., Gibbs C. J.: Intraneuronal aluminium accumulation in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Science 1982, 217, 1053-1055.
• 23. Quartley B., Esselmont G., Taylor A., Dobrota M.: Effect of oral aluminium citrate on short-term tissue distribution of aluminium. Food. Chem. Toxic. 1993, 31, 543-548.
• 24. Renton K. A., Manchester K. L., Kilroe-Smith T. A.: The transport of aluminium and water across the rat small intestine. J. Inorg. Biochem. 1993, 50, 21-29.
• 25. Scherp H. W., Church C. F.: Neurotoxic action of aluminium salts. Proc. Soc. Exp. Biol. Med. 1937, 36, 851-853.
• 26. Soni M. G., White S. M., Flamm W. G., Burdock G. A.: Safety evaluation of dietary aluminium. Reg. Toxicol. Pharmacol. 2001, 33, 66-79.
• 27. Węgiel J., Wiśniewski H. M., Morys J., Bobiński M., Sołtysiak Z.: Animal models of brain amyloidosis. Acta Neurobiol. Exp. 1992, 52, 123.
• 28. Wisniewski H. M., Wen G. Y.: Aluminium and Alzheimer’s disease. Proc. Ciba Fundation Symposium 169: Aluminium in Biology and Medicine. Wley, Chichester 1992, 142-146.
• 29. Yokel R. A.: Toxicity of gestational aluminium exposure to the Materna rabbit and offspring. Toxic. Appl. Pharmacol. 1985, 79, 121-133.
• 30. Yumoto S., Nagai H., Kobayashi K., Tamte A., Kakimi S., Matsuzaki H.: 26Al incorporation into the brain of suckling rats through maternal milk. J. Inorg. Biochem. 2003, 97, 155-160.
• 31. Zatta P., Ibn-Lkhayat-Idrissi M., Zambenedetti P., Kilyen M., Kiss T.: In vivo and in vitro effects of aluminium on the activity of mouse brain acetylocholinesterase. Brain Res. Bull. 2002, 59, 41-45.
• 32. Zatta P., Nicolini M., Corani B.: AL.(III) toxicity and blood-brain barrier permeability, [w:] Nicolini M., Zatta P., Corani B.: Aluminium in Chemistry, Biology and Medicine. Raven Press. New York 1991, s. 97-112.
• 33. Zatta P. F.: Controversial aspects of aluminium (III) accumulation and subcompartmentation in Alzheimer’s disease. Trace Elem. Med. 1993, 10, 120-128.